Triptolide Attenuates Vascular Calcification by Upregulating Expression of miRNA-204

Area of Science:

• Cardiovascular Research
• Molecular Biology
• Pharmacology

Background:

• Triptolide (TP), a natural compound from Tripterygium wilfordii, has known cardiovascular benefits.
• The precise molecular mechanisms of TP's protective effects, particularly in vascular calcification, remain unclear.

Purpose of the Study:

• To investigate the protective role of TP against medial vascular calcification in a rat model.
• To determine if TP attenuates vascular calcification by upregulating miRNA-204.

Main Methods:

• Vascular calcification induced in rats using Vitamin D3 plus nicotine.
• Assessed calcification via Von Kossa and Hematoxylin-Eosin staining, calcium content, and alkaline phosphatase activity.
• Quantified miRNA-204 expression using qRT-PCR; detected RUNX2 and BMP2 expression via immunohistochemistry and western blotting.

Main Results:

• TP significantly reduced vascular calcification, alkaline phosphatase activity, and calcium content in a dose-dependent manner.
• TP administration decreased the expression of BMP2 and RUNX2.
• TP upregulated miRNA-204, and this effect was reversed by miRNA-204-interfering lentivirus.

Conclusions:

• Triptolide inhibits BMP2 and RUNX2 expression, thereby attenuating vascular calcification.
• TP upregulates miRNA-204, suggesting a key role in its protective mechanism.
• TP presents a potential therapeutic strategy for treating vascular calcification.